Drug
Paclitaxel poliglumex clinical trials
Also written Xyotax, CT-2103 and PG-TXL.
- studies test it
- 19
- open now
- 0
- in phase 3
- 4
- first study started
- 2001
How studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 12
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 15
CTI BioPharma (4) · Gynecologic Oncology Group (2) · University of Southern California (2) · State University of New York - Upstate Medical University (1) · Brown University (1) · Alliance for Clinical Trials in Oncology (1) · The Methodist Hospital Research Institute (1) · Dartmouth-Hitchcock Medical Center (1)
Often tested with
Tested in the same studies.
Carboplatin (4) · Capecitabine (2) · Cetuximab (1) · Pemetrexed (1) · Gemcitabine (1) · Paclitaxel (1) · Estradiol (1) · Doxorubicin (1)
Studies
Open first, then newest update. How each study uses paclitaxel poliglumex is read from its arms, and is right about nine times in ten.
Testing it · 19
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck CancerCompletedPhase 1/2State University of New York - Upstate Medical UniversityNCT00660218Written as paclitaxel poliglumex
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube CancerStatus unknownPhase 3GOG FoundationNCT00108745Written as Paclitaxel Poliglumex
- A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.TerminatedPhase 3CTI BioPharmaNCT00269828Written as paclitaxel poliglumex
- CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mLWithdrawnPhase 3CTI BioPharmaNCT00576225Written as CT-2103/carboplatin
- Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTerminatedPhase 3CTI BioPharmaNCT00551733Written as paclitaxel poliglumex
- PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT MethylationCompletedPhase 2Brown UniversityNCT01402063Written as PPX (CT2103)
- CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedPhase 2Gynecologic Oncology GroupNCT00045682Written as Paclitaxel Poliglumex
- Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerWithdrawnPhase 2University of Southern CaliforniaNCT01227408Written as doxorubicin, paclitaxel poliglumex, capecitabine, cyclophosphamide, methotrexate
- Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate CancerTerminatedPhase 2OHSU Knight Cancer InstituteNCT00459810Written as paclitaxel poliglumex
- A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung CancerTerminatedPhase 2Washington University School of MedicineNCT00352690Written as Paclitaxel poliglumex
- Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00265733Written as paclitaxel poliglumex
- Efficacy and Safety Study of Xyotax to Treat Prostate CancerCompletedPhase 2The Methodist Hospital Research InstituteNCT00446836Written as Paclitaxel polyglumex (Xyotax)
- Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerCompletedPhase 1Gynecologic Oncology GroupNCT00060359Written as Paclitaxel Poliglumex
- A Pilot Study of PPX in Women With Metastatic Colorectal CancerCompletedPhase 1University of Southern CaliforniaNCT00598247Written as Paclitaxel Poliglumex
- Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)CompletedPhase 2Dartmouth-Hitchcock Medical CenterNCT00487669Written as paclitaxel poliglumex, pemetrexed
- CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal CancerCompletedPhase 1/2Memorial Sloan Kettering Cancer CenterNCT00017017Written as paclitaxel poliglumex
- CT-2103 in Combination With Gemcitabine in Metastatic Breast CancerCompletedPhase 1M.D. Anderson Cancer CenterNCT00270907Written as CT-2103
- Phase II CT-2103/Carboplatin in Ovarian CancerCompletedPhase 2CTI BioPharmaNCT00069901Written as CT-2103 (poly(L)glutamate-paclitaxel)
- Study of Xyotax (CT-2103) in Patients With Metastatic Breast CancerCompletedPhase 2Dana-Farber Cancer InstituteNCT00148707Written as CT-2103 (Xyotax)
Given in every arm · 1 — paclitaxel poliglumex is usual care beside what is tested
Codes
What other systems call paclitaxel poliglumex · ClinicalTrials.gg INT004890
- MeSH (NLM) C509139paclitaxel poliglumexConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) TQ64FZ98ZNPACLITAXEL POLIGLUMEXConfirmed FDA, NLM, Wikidata
- RxNorm 2473230One source FDA
- Wikidata Q72499389paclitaxel poliglumexConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1795Paclitaxel PoliglumexOne source FDA
- DrugBank DB13809One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C509139 | paclitaxel poliglumex | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | TQ64FZ98ZN | PACLITAXEL POLIGLUMEX | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2473230 | — | One source FDA |
| Wikidata | Q72499389 | paclitaxel poliglumex | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1795 | Paclitaxel Poliglumex | One source FDA |
| DrugBank | DB13809 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.